Search results for "immunology and allergy"

showing 10 items of 2868 documents

The B-cell receptor in control of tumor B-cell fitness: Biology and clinical relevance

2019

Surface expression of a functional B cell antigen receptor (BCR) is essential for the survival and proliferation of mature B cells. Most types of B-cell lymphoproliferative disorders retain surface BCR expression, including B-cell non-Hodgkin lymphomas (B-NHL) and chronic lymphocytic leukemia (CLL). Targeting BCR effectors in B-NHL cell lines in vitro has indicated that this signaling axis is crucial for malignant B cell growth. This has led to the development of inhibitors of BCR signaling, which are currently used for the treatment of CLL and several B-NHL subtypes. Recent studies based on conditional BCR inactivation in a MYC-driven mouse B-cell lymphoma model have revisited the role of …

0301 basic medicinetumor cell fitnessChronic lymphocytic leukemiaImmunologyB-cell receptorPopulationReceptors Antigen B-CellLymphoproliferative disorderslymphomaBiologyMice03 medical and health sciences0302 clinical medicineimmune system diseaseshemic and lymphatic diseasesB-cell receptorTumor MicroenvironmentmedicineAnimalsHumansImmunology and AllergyeducationHematologic NeoplasmB cellBCR inhibitorB-Lymphocyteseducation.field_of_studyAnimalB-Lymphocytebreakpoint cluster regionB-cell receptor; BCR inhibitors; c-MYC; lymphoma; lymphoma resistance; tumor cell fitnesslymphoma resistancemedicine.diseaseLymphoproliferative DisordersLymphomaBCR inhibitorsPhenotype030104 developmental biologymedicine.anatomical_structurec-MYCtumor cell fitneCell cultureLymphoproliferative DisorderHematologic NeoplasmsCancer researchHumanSignal Transduction030215 immunology
researchProduct

Ammonium thiolactate and thiolactic acid: important hairdressers' allergens?

2002

030201 allergyAllergyThiolactic acidbusiness.industryDermatologymedicine.diseasemedicine.disease_cause030207 dermatology & venereal diseases03 medical and health scienceschemistry.chemical_compound0302 clinical medicineAllergenAmmonium thiolactatechemistryContact allergyImmunopathologyImmunologymedicineImmunology and AllergyOccupational exposurebusinessContact dermatitisContact Dermatitis
researchProduct

New insights into the pathogenesis of giant cell arteritis

2017

Giant cell arteritis (GCA) is an inflammatory chronic disease occurring exclusively in elderly individuals. Until recently, the disease has been considered a unique disease resulting from the interaction in the walls of susceptible arteries, between an unknown infectious agents with local dendritic cells (DCs), activated CD4 T cells and effector macrophages. Recent evidence has shown that this view was too simplistic and has clarified many of the pathogenetic aspects of the disease. Many genetic studies recently published have identified different new genes, including cytokines, adhesion molecules and regulators of innate immunity, as crucial players in the development and progression of GC…

030203 arthritis & rheumatology0301 basic medicineImmunology and Allergy; ImmunologyInnate immune systemGiant Cell ArteritisImmunologyContext (language use)DiseaseBiologymedicine.diseasePathogenesisSettore MED/16 - Reumatologia03 medical and health sciencesGiant cell arteritis030104 developmental biology0302 clinical medicineImmune systemLymphatic systemAntigenImmunologymedicineAnimalsHumansImmunology and Allergyskin and connective tissue diseases
researchProduct

Reply

2017

030203 arthritis & rheumatology0301 basic medicinebusiness.industryImmunologymedicine.disease03 medical and health sciencesPsoriatic arthritis030104 developmental biology0302 clinical medicineImmune systemRheumatologyImmunologyImmunology and AllergyMedicineIn patientbusinessArthritis & Rheumatology
researchProduct

FRI0349 PSORIATIC ARTHRITIS AND CENTRAL OBESITY: STRONG ASSOCIATION WITH FUNCTIONAL DISABILITY AND A WORSE QUALITY OF LIFE

2020

Background:Psoriatic arthritis (PsA) is a chronic inflammatory arthritis associated with comorbidities like obesity, metabolic syndrome, and cardiovascular disease. Adipose tissue leads to a pro-inflammatory status in obese subjects. For this reason, central obesity may determine a worsening in both disability index or quality of life in PsA patients treated with biologic agents.Objectives:Our study aimed to evaluate the relationship between central obesity and disability index or the impact of the disease on quality of life in a real-world sample of PsA patients.Methods:A cross-sectional study was conducted. Patients with PsA were enrolled at the PsA clinic at the ARNAS Civico in Palermo (…

030203 arthritis & rheumatology0301 basic medicinemedicine.medical_specialtypsoriatic arthriticentral obesitybusiness.industryInflammatory arthritisImmunologyArthritismedicine.diseaseGeneral Biochemistry Genetics and Molecular Biology03 medical and health sciencesPsoriatic arthritis030104 developmental biology0302 clinical medicineRheumatologyQuality of lifeInternal medicineRheumatoid arthritisDiabetes mellitusmedicineImmunology and AllergyFunctional abilityMetabolic syndromebusinessAnnals of the Rheumatic Diseases
researchProduct

Physical capacity in performing daily activities is reduced in scleroderma patients with early lung involvement

2015

Background and Aims Patients with systemic sclerosis (SSc) often complain reduced capacity at submaximal exercise; conversely, physical capacity in performing daily duties has never been measured in SSc. The aim of this study is to evaluate this performance and its correlates, in patients with SSc compared with healthy controls, in a free-living setting. Methods Twenty-seven outpatients with stable SSc and 11 controls were recruited. Physical activity was assessed by portable multiple sensor device (SenseWear Armband) worn for at least 6 days. Physical activity duration (PAD; in minutes) for non-sedentary activities and physical activity level (PAL = total daily energy/resting energy expend…

030203 arthritis & rheumatologyPulmonary and Respiratory MedicineSpirometrymedicine.medical_specialtyActivities of daily livingmedicine.diagnostic_testbusiness.industrymedicine.diseasePhysical activity levelScleroderma03 medical and health sciences0302 clinical medicine030228 respiratory systemDLCOInternal medicinemedicinePhysical therapyCardiologyImmunology and AllergyResting energy expenditurebusinessBioelectrical impedance analysisBody mass indexGenetics (clinical)The Clinical Respiratory Journal
researchProduct

FRI0265 Selexipag in Raynaud's Phenomenon Secondary To Systemic Sclerosis: A Randomised, Placebo-Controlled, Phase II Study

2016

Background Raynaud9s phenomenon (RP) occurs in >95% of patients (pts) with systemic sclerosis (SSc) and contributes to digital ischaemia that may lead to digital ulcers (DUs) and gangrene.1,2 Empirical treatment of SSc-associated RP includes oral vasodilators, particularly calcium channel blockers and intermittent intravenous prostacyclin analogues.3,4 However, there is a need to identify oral therapies that are more efficacious than those currently available. Objectives To determine the activity of selexipag, an oral, selective, prostacyclin receptor agonist, on RP attack frequency in pts with SSc. Methods The study comprised a placebo single-blind run-in phase of 2–4-weeks followed by an …

030203 arthritis & rheumatologymedicine.medical_specialtyFuture studiesStudy drugbusiness.industryImmunologyPhases of clinical researchCondition scoreSelexipagPlaceboGeneral Biochemistry Genetics and Molecular Biology03 medical and health scienceschemistry.chemical_compoundSafety profile0302 clinical medicineRheumatologychemistryInternal medicinemedicineImmunology and Allergy030212 general & internal medicinebusinessAdverse effectAnnals of the Rheumatic Diseases
researchProduct

Organisation des structures de soins transversales en allergologie en France en 2020

2021

Resume Introduction Les allergies touchent 25 % de la population generale avec une augmentation des allergies severes. Le developpement en France de structures de soins transversales en allergologie pour une prise en charge pluridisciplinaire des patients repond a un besoin de sante publique. Notre travail a pour but de faire un etat des lieux de ces structures. Methodes Enquete descriptive par questionnaire envoye aux chefs de services de structures de soins soit avec une activite principale en allergologie, soit avec une activite variee en allergologie. L’enquete portait sur l’organisation administrative, les equipes medicales et paramedicales, l’offre de soins et les moyens techniques de…

030207 dermatology & venereal diseases03 medical and health sciences0302 clinical medicine030228 respiratory systemImmunology and AllergyRevue Française d'Allergologie
researchProduct

15. Mainzer Allergie-Workshop 2003

2003

030207 dermatology & venereal diseases03 medical and health sciencesmedicine.medical_specialty0302 clinical medicine030228 respiratory systemOtorhinolaryngologybusiness.industryFamily medicinemedicineImmunology and AllergybusinessAllergo Journal
researchProduct

Therapiemöglichkeiten bei der IgE-vermittelten Nahrungsmittel-Allergie

2002

Erst nachdem die klinische Relevanz einer Nahrungsmittelallergie eindeutig nachgewiesen ist, erfolgt die therapeutische Intervention. Hierbei stellt die Karenz den wichtigsten Pfeiler dar. Wegen der Komplexitat der Nahrungsmittelallergie mussen die jeweiligen Karenzempfehlungen jedoch immer individuell erarbeitet werden. Die Voraussetzungen hierzu schafft die Ernahrungstherapie, die gleichzeitig die bedarfsdeckende Ernahrung im Blick hat. Die Ernahrungstherapie erfolgt in enger Abstimmung zwischen Arzt und allergologischer Ernahrungsfachkraft. Fehlernahrung durch einseitige Diaten muss aufjeden Fall vermieden werden. Nach ein- bis zweijahriger Allergenkarenz kann eine Reexposition erwogen w…

030207 dermatology & venereal diseases030201 allergy03 medical and health sciences0302 clinical medicineImmunology and Allergy3. Good healthAllergo Journal
researchProduct